−450KRW
−12.73 BKRW
31.72 BKRW
21.25 M
About MEZZION PHARMA
Sector
CEO
Dong-Hyun Park
Headquarters
Seoul
Website
Employees (FY)
21
Founded
2002
ISIN
KR7140410002
FIGI
BBG0029RPD64
Mezzion Pharma Co., Ltd. engages in the development, production, and licensing of pharmaceutical products. Its products include erectile dysfunction, benign prostatic hyperplasia, and fontan therapeutic drugs. The company was founded by Park, Dong-Hyun on September 25, 2002 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 140410 is 36300 KRW — it has decreased by 0.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange MEZZION PHARMA stocks are traded under the ticker 140410.
MEZZION PHARMA is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
140410 stock is 3.24% volatile and has beta coefficient of −0.30. Check out the list of the most volatile stocks — is MEZZION PHARMA there?
Yes, you can track MEZZION PHARMA financials in yearly and quarterly reports right on TradingView.
140410 stock has fallen by 4.97% compared to the previous week, the month change is a 11.89% fall, over the last year MEZZION PHARMA has showed a 75.36% increase.
140410 net income for the last quarter is −6.34 B KRW, while the quarter before that showed −977.89 M KRW of net income which accounts for −548.84% change. Track more MEZZION PHARMA financial stats to get the full picture.
Today MEZZION PHARMA has the market capitalization of 1.08 T, it has increased by 3.29% over the last week.
No, 140410 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 140410 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEZZION PHARMA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 21.00 employees. See our rating of the largest employees — is MEZZION PHARMA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEZZION PHARMA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEZZION PHARMA stock shows the buy signal. See more of MEZZION PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEZZION PHARMA EBITDA is −13.08 B KRW, and current EBITDA margin is −40.80%. See more stats in MEZZION PHARMA financial statements.